Logo image of HMC

HONDA MOTOR CO LTD-SPONS ADR (HMC) Stock Fundamental Analysis

NYSE:HMC - New York Stock Exchange, Inc. - US4381283088 - ADR - Currency: USD

29.68  +0.48 (+1.64%)

After market: 29.59 -0.09 (-0.3%)

Fundamental Rating

5

Overall HMC gets a fundamental rating of 5 out of 10. We evaluated HMC against 37 industry peers in the Automobiles industry. While HMC has a great profitability rating, there are quite some concerns on its financial health. HMC is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

HMC had positive earnings in the past year.
HMC had a positive operating cash flow in the past year.
Each year in the past 5 years HMC has been profitable.
HMC had a positive operating cash flow in each of the past 5 years.
HMC Yearly Net Income VS EBIT VS OCF VS FCFHMC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500B -500B 1T 1.5T 2T

1.2 Ratios

With an excellent Return On Assets value of 2.72%, HMC belongs to the best of the industry, outperforming 81.08% of the companies in the same industry.
HMC has a better Return On Equity (6.78%) than 78.38% of its industry peers.
HMC has a better Return On Invested Capital (3.85%) than 78.38% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HMC is below the industry average of 6.62%.
The 3 year average ROIC (3.64%) for HMC is below the current ROIC(3.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.72%
ROE 6.78%
ROIC 3.85%
ROA(3y)3.02%
ROA(5y)3%
ROE(3y)7.11%
ROE(5y)7.06%
ROIC(3y)3.64%
ROIC(5y)3.36%
HMC Yearly ROA, ROE, ROICHMC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 3.85%, HMC belongs to the top of the industry, outperforming 83.78% of the companies in the same industry.
HMC's Profit Margin has improved in the last couple of years.
The Operating Margin of HMC (5.59%) is better than 83.78% of its industry peers.
HMC's Operating Margin has improved in the last couple of years.
HMC's Gross Margin of 21.50% is amongst the best of the industry. HMC outperforms 86.49% of its industry peers.
In the last couple of years the Gross Margin of HMC has remained more or less at the same level.
Industry RankSector Rank
OM 5.59%
PM (TTM) 3.85%
GM 21.5%
OM growth 3Y-2.23%
OM growth 5Y5.68%
PM growth 3Y-7.43%
PM growth 5Y4.77%
GM growth 3Y1.59%
GM growth 5Y0.84%
HMC Yearly Profit, Operating, Gross MarginsHMC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HMC is still creating some value.
HMC has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HMC has more shares outstanding
HMC has a worse debt/assets ratio than last year.
HMC Yearly Shares OutstandingHMC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
HMC Yearly Total Debt VS Total AssetsHMC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10T 20T 30T

2.2 Solvency

HMC has an Altman-Z score of 1.65. This is a bad value and indicates that HMC is not financially healthy and even has some risk of bankruptcy.
HMC's Altman-Z score of 1.65 is fine compared to the rest of the industry. HMC outperforms 78.38% of its industry peers.
HMC has a Debt/Equity ratio of 0.56. This is a neutral value indicating HMC is somewhat dependend on debt financing.
The Debt to Equity ratio of HMC (0.56) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Altman-Z 1.65
ROIC/WACC1.33
WACC2.89%
HMC Yearly LT Debt VS Equity VS FCFHMC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2T 4T 6T 8T 10T

2.3 Liquidity

HMC has a Current Ratio of 1.36. This is a normal value and indicates that HMC is financially healthy and should not expect problems in meeting its short term obligations.
HMC has a better Current ratio (1.36) than 62.16% of its industry peers.
A Quick Ratio of 1.07 indicates that HMC should not have too much problems paying its short term obligations.
The Quick ratio of HMC (1.07) is better than 67.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.07
HMC Yearly Current Assets VS Current LiabilitesHMC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2T 4T 6T 8T 10T

3

3. Growth

3.1 Past

HMC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.83%.
The Earnings Per Share has been decreasing by -7.46% on average over the past years.
The Revenue has been growing slightly by 6.17% in the past year.
Measured over the past years, HMC shows a small growth in Revenue. The Revenue has been growing by 7.75% on average per year.
EPS 1Y (TTM)-21.83%
EPS 3Y-21.31%
EPS 5Y-7.46%
EPS Q2Q%-86%
Revenue 1Y (TTM)6.17%
Revenue growth 3Y14.23%
Revenue growth 5Y7.75%
Sales Q2Q%-1.28%

3.2 Future

HMC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.72% yearly.
HMC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.72% yearly.
EPS Next Y27.23%
EPS Next 2Y18.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.52%
Revenue Next 2Y1.72%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HMC Yearly Revenue VS EstimatesHMC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5T 10T 15T 20T
HMC Yearly EPS VS EstimatesHMC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500 1K 1.5K

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.53 indicates a rather cheap valuation of HMC.
91.89% of the companies in the same industry are more expensive than HMC, based on the Price/Earnings ratio.
HMC is valuated cheaply when we compare the Price/Earnings ratio to 27.28, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 5.92, the valuation of HMC can be described as very cheap.
Based on the Price/Forward Earnings ratio, HMC is valued cheaper than 91.89% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.76. HMC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.53
Fwd PE 5.92
HMC Price Earnings VS Forward Price EarningsHMC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

HMC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HMC is cheaper than 91.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.35
HMC Per share dataHMC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

HMC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HMC has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as HMC's earnings are expected to grow with 18.72% in the coming years.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y18.72%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.07%, HMC is a good candidate for dividend investing.
HMC's Dividend Yield is rather good when compared to the industry average which is at 3.84. HMC pays more dividend than 94.59% of the companies in the same industry.
HMC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 5.07%

5.2 History

The dividend of HMC decreases each year by -7.66%.
HMC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-7.66%
Div Incr Years0
Div Non Decr Years0
HMC Yearly Dividends per shareHMC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

5.3 Sustainability

41.61% of the earnings are spent on dividend by HMC. This is a bit on the high side, but may be sustainable.
DP41.61%
EPS Next 2Y18.72%
EPS Next 3YN/A
HMC Yearly Income VS Free CF VS DividendHMC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500B -500B 1T
HMC Dividend Payout.HMC Dividend Payout, showing the Payout Ratio.HMC Dividend Payout.PayoutRetained Earnings

HONDA MOTOR CO LTD-SPONS ADR

NYSE:HMC (7/2/2025, 8:04:00 PM)

After market: 29.59 -0.09 (-0.3%)

29.68

+0.48 (+1.64%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)05-13 2025-05-13/dmh
Earnings (Next)08-05 2025-08-05/amc
Inst Owners41.07%
Inst Owner Change0.01%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap41.06B
Analysts76.8
Price Target31.87 (7.38%)
Short Float %0.43%
Short Ratio6.17
Dividend
Industry RankSector Rank
Dividend Yield 5.07%
Yearly Dividend1.69
Dividend Growth(5Y)-7.66%
DP41.61%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-28 2025-03-28 (34)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-30.64%
Min EPS beat(2)-80.57%
Max EPS beat(2)19.29%
EPS beat(4)2
Avg EPS beat(4)-29.71%
Min EPS beat(4)-80.57%
Max EPS beat(4)19.29%
EPS beat(8)5
Avg EPS beat(8)1.89%
EPS beat(12)6
Avg EPS beat(12)-1.3%
EPS beat(16)10
Avg EPS beat(16)9.75%
Revenue beat(2)1
Avg Revenue beat(2)0.46%
Min Revenue beat(2)-0.89%
Max Revenue beat(2)1.81%
Revenue beat(4)3
Avg Revenue beat(4)0.68%
Min Revenue beat(4)-0.89%
Max Revenue beat(4)1.81%
Revenue beat(8)4
Avg Revenue beat(8)0.08%
Revenue beat(12)6
Avg Revenue beat(12)0.08%
Revenue beat(16)8
Avg Revenue beat(16)0.23%
PT rev (1m)-10.93%
PT rev (3m)-10.42%
EPS NQ rev (1m)1.86%
EPS NQ rev (3m)-13.28%
EPS NY rev (1m)1.86%
EPS NY rev (3m)0.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 7.53
Fwd PE 5.92
P/S 0.27
P/FCF N/A
P/OCF 20.26
P/B 0.48
P/tB 0.53
EV/EBITDA 6.35
EPS(TTM)3.94
EY13.27%
EPS(NY)5.01
Fwd EY16.89%
FCF(TTM)-2.78
FCFYN/A
OCF(TTM)1.46
OCFY4.94%
SpS108.76
BVpS61.81
TBVpS56.16
PEG (NY)0.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.72%
ROE 6.78%
ROCE 5.48%
ROIC 3.85%
ROICexc 4.89%
ROICexgc 5.23%
OM 5.59%
PM (TTM) 3.85%
GM 21.5%
FCFM N/A
ROA(3y)3.02%
ROA(5y)3%
ROE(3y)7.11%
ROE(5y)7.06%
ROIC(3y)3.64%
ROIC(5y)3.36%
ROICexc(3y)4.65%
ROICexc(5y)4.25%
ROICexgc(3y)4.94%
ROICexgc(5y)15.11%
ROCE(3y)5.42%
ROCE(5y)5.03%
ROICexcg growth 3Y-46.73%
ROICexcg growth 5Y7.95%
ROICexc growth 3Y6.2%
ROICexc growth 5Y7.78%
OM growth 3Y-2.23%
OM growth 5Y5.68%
PM growth 3Y-7.43%
PM growth 5Y4.77%
GM growth 3Y1.59%
GM growth 5Y0.84%
F-Score4
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Debt/EBITDA 3.55
Cap/Depr 114.08%
Cap/Sales 3.91%
Interest Coverage 2.76
Cash Conversion 14.93%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.07
Altman-Z 1.65
F-Score4
WACC2.89%
ROIC/WACC1.33
Cap/Depr(3y)92.78%
Cap/Depr(5y)88.03%
Cap/Sales(3y)3.54%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.83%
EPS 3Y-21.31%
EPS 5Y-7.46%
EPS Q2Q%-86%
EPS Next Y27.23%
EPS Next 2Y18.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.17%
Revenue growth 3Y14.23%
Revenue growth 5Y7.75%
Sales Q2Q%-1.28%
Revenue Next Year0.52%
Revenue Next 2Y1.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.19%
EBIT growth 3Y11.68%
EBIT growth 5Y13.88%
EBIT Next Year23463.7%
EBIT Next 3Y536.45%
EBIT Next 5YN/A
FCF growth 1Y-500.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.9%
OCF growth 3Y-44.18%
OCF growth 5Y-21.49%